SCHEMBL23349028

SCHEMBL23349028

O=C1C(=O)c2ccc(-c3cccc4ccccc34)c3cccc1c23

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.58
ALDH1A1 P00352 3/20 0.58
CES2 O00748 2/20 0.58
BCHE P06276 2/20 0.58
MCL1 Q07820 1/20 0.58
DNMT1 P26358 2/20 0.55
KDM4E B2RXH2 3/20 0.50
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
PABPC1 P11940 2/20 0.50
CASP1 P29466 2/20 0.50
CYP3A4 P08684 1/20 0.50
CASP7 P55210 1/20 0.50
PTPN1 P18031 1/20 0.50
ALPL P05186 1/20 0.46
GAA P10253 1/20 0.46
POLB P06746 2/20 0.44
MAPK1 P28482 2/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31619746 1.00 CES1 (0.58) CES1ALDH1A1CES2BCHEMCL1
SCHEMBL15673011 0.85 ALDH1A1 (0.59) ALDH1A1DNMT1KDM4EMAPTSMN1; SMN2
SCHEMBL20988450 0.84 TYMS (0.61) ALDH1A1DNMT1KDM4EMAPTSMN1; SMN2
SCHEMBL13045525 0.82 PABPC1 (0.50) CES1ALDH1A1MCL1DNMT1KDM4E
SCHEMBL6077039 0.82 ALDH1A1 (0.56) ALDH1A1DNMT1KDM4EMAPTSMN1; SMN2
SCHEMBL31619723 0.81 CES1 (0.72) CES1ALDH1A1CES2BCHEMCL1
SCHEMBL13045522 0.81 PABPC1 (0.72) CES1ALDH1A1CES2BCHEMCL1
SCHEMBL29456701 0.81 PABPC1 (0.72) CES1ALDH1A1CES2BCHEMCL1
SCHEMBL14680387 0.81 PTPN1 (0.41) CES1ALDH1A1CES2BCHEMCL1
SCHEMBL2328517 0.80 ALDH1A1 (0.48) ALDH1A1DNMT1KDM4ECASP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139417-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139417-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CYP1A1, POU2F1, NFE2L2 CES1 1428/4885ALDH1A1 252/4885CES2 1484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.